01 | MD Anderson Cancer Center

Multi-center study reveals unique subtypes of most common...

January 28, 2016

An international collaborative study has revealed detailed new information about diffuse glioma, the most common type of tumor found...

MD Anderson joins nation’s cancer centers in endorsement of...

BY Kelly Miller

January 27, 2016

In response to low national vaccination rates for the human papillomavirus (HPV), The University of Texas MD Anderson Cancer Center...

Targeted Axillary Dissection of lymph nodes after...

BY Kelly Miller

January 25, 2016

A new procedure developed by surgeons at The University of Texas MD Anderson Cancer Center improves the accuracy of axillary staging...

Potential therapeutic targets identified for multiple sclerosis

January 25, 2016

Treatment of multiple sclerosis (MS) and other inflammatory diseases may benefit by new findings from a study that identified...

New findings may enhance PARP inhibitors therapy in breast...

BY Kelly Miller

January 18, 2016

Findings from a new study reveal that PARP inhibitors, an emerging class of drugs being studied in cancer clinical trials, may be...

MD Anderson and Enumeral enter into collaborative research...

BY Kelly Miller

January 11, 2016

The University of Texas MD Anderson Cancer Center today announced that it has entered into a collaborative research and development...

MD Anderson and Kymab announce research and development strategic...

January 07, 2016

Kymab, a leading human monoclonal antibody biopharmaceutical company, and The University of Texas MD Anderson Oncology Research for...

Lymphoma/Myeloma symposium for patients and caregivers set...

BY Kelly Miller

January 06, 2016

Patients with lymphoma or myeloma and their caregivers will have access to leading experts in this field of cancer during an upcoming...

January 2016

January 2016 Archive

Multi-center study reveals unique subtypes of most common...

MD Anderson joins nation’s cancer centers in endorsement of...

Targeted Axillary Dissection of lymph nodes after...

Potential therapeutic targets identified for multiple sclerosis

New findings may enhance PARP inhibitors therapy in breast...

MD Anderson and Enumeral enter into collaborative research...

MD Anderson and Kymab announce research and development strategic...

Lymphoma/Myeloma symposium for patients and caregivers set...

Help #EndCancer

January 2016

January 2016 Archive

Help #EndCancer

Give Now

Donate Blood

Shop MD Anderson